NCT03599752 - Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions

Colorectal AdenocarcinomaColorectal Carcinoma Metastatic in the LungStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8

Interventions

DRUG

Chemotherapy

Receive chemotherapy

PROCEDURE

Metastasectomy

Undergo pulmonary metastasectomy

Trial Locations (6)

19107

Thomas Jefferson University, Philadelphia

63110

Washington University School of Medicine, St Louis

77030

Baylor Colllege of Medicine, Houston

M D Anderson Cancer Center, Houston

M5G 2M9

University Health Network Princess Margaret Cancer Center P2C, Toronto

H3T 1J7

University of Montreal, Montreal

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER